Healthy Liver - Healthy Brain
Diet Intervention to Promote Liver and Brain Health in Adults With Non-alcoholic Fatty Liver Disease
1 other identifier
interventional
55
1 country
1
Brief Summary
People with liver disease report difficulties with attention and problem-solving skills. Diet plays an important role in the development of liver disease and/or pre-diabetes. The purpose of this study is to examine whether participation in a brief diet intervention (up to 3 weeks) can improve brain and liver health and function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2021
CompletedFirst Posted
Study publicly available on registry
February 1, 2022
CompletedStudy Start
First participant enrolled
May 18, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedNovember 21, 2024
November 1, 2024
2.2 years
December 30, 2021
November 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Decrease in Liver Fat
Hepatic triglyceride level will be assessed using liver 1H MRS.
Liver fat will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The liver 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).
Decrease in cerebral gluatamate
Cerebral glutamate levels will be measured using 1H MRS.
Cerebral glutamate will be measured at baseline (week 0) and after at least 2 weeks (up to 3 weeks) on the designated diet. The brain 1H MRS scans will happen during Visit 3 (baseline) and Visit 4 (at least 2 weeks on the diet).
Study Arms (2)
Low-carbohydrate diet
EXPERIMENTALParticipants assigned to the Low-carbohydrate diet will be instructed to limit carbohydrate intake to \<30 g/d.
Low-calorie diet
ACTIVE COMPARATORParticipants assigned to the Low-calorie diet will be instructed to reduce their energy intake to match the LoCHO block (we are predicting \~1200 kcal/d for women and \~1500 kcal/d for men, following current recommendations for treatment of NAFLD).
Interventions
Meal will be prepared and delivered by SNAP Kitchen, which has 7 locations in Austin and offers 20+ options for low-carbohydrate and low-calorie meals, each meal available in different sizes varying in energy intake. Meals will be entered into the Nutrition Data System for Research (NDS-R) software to confirm low-calorie profile. Meals will be delivered to participants' homes twice a week.
Eligibility Criteria
You may qualify if:
- at least 40 years of age
- English speakers
- show a minimum of 5% hepatic triglyceride level on liver imaging
- have not taken part in a weight loss/dietary intervention within 6 months
- not currently adhering to a low-carbohydrate diet (e.g., Atkins, Paleo)
You may not qualify if:
- younger than 40 years of age
- have a history of neurological disease (e.g. stroke, seizure disorder)
- psychiatric illness (e.g. schizophrenia, bipolar disorder)
- harmful alcohol use (AUDIT-C score \>5)
- morbid obesity (BMI\>40)
- MRI contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Texas at Austin
Austin, Texas, 78712, United States
Related Publications (5)
Browning JD, Baker JA, Rogers T, Davis J, Satapati S, Burgess SC. Short-term weight loss and hepatic triglyceride reduction: evidence of a metabolic advantage with dietary carbohydrate restriction. Am J Clin Nutr. 2011 May;93(5):1048-52. doi: 10.3945/ajcn.110.007674. Epub 2011 Mar 2.
PMID: 21367948BACKGROUNDErvin RB. Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003-2006. Natl Health Stat Report. 2009 May 5;(13):1-7.
PMID: 19634296BACKGROUNDHaley AP, Gonzales MM, Tarumi T, Tanaka H. Subclinical vascular disease and cerebral glutamate elevation in metabolic syndrome. Metab Brain Dis. 2012 Dec;27(4):513-20. doi: 10.1007/s11011-012-9306-x. Epub 2012 May 3.
PMID: 22552897BACKGROUNDOh R, Gilani B, Uppaluri KR. Low-Carbohydrate Diet. 2023 Aug 17. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK537084/
PMID: 30725769BACKGROUNDCrabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology. 2020 Jan;71(1):306-333. doi: 10.1002/hep.30866. No abstract available.
PMID: 31314133BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreana Haley, PhD
Department of Psychology, University of Texas at Austin
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor in Clinical Psychology
Study Record Dates
First Submitted
December 30, 2021
First Posted
February 1, 2022
Study Start
May 18, 2022
Primary Completion
August 3, 2024
Study Completion
September 1, 2024
Last Updated
November 21, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.